HL

Olivier Casasnovas | ASCO 2018 | Value of PET-driven therapy in advanced-stage HL

Sara Valente , Jun 8, 2018

English & Italian

FL

Stefano Luminari | ASCO 2018 | Overview of high-risk follicular lymphomas

Stefano Luminari , Jun 8, 2018

DLBCL

Frederick Locke | ASCO 2018 | Axi-cel DoR in R/R large B-Cell Lymphoma patients in ZUMA-1

Sara Valente , Jun 8, 2018

DLBCL

Laurie Sehn | ASCO 2018 | Polatuzumab vedotin, bendamustine and rituximab combination for R/R DLBCL

Sara Valente , Jun 8, 2018

English & French

CLL/SLL,   DLBCL,  FL,  HL,   & 1 more

Gilles Salles | Welcome to ASCO 2018: Message from our Chair

Gilles Salles , Jun 5, 2018

HL

Gilles Salles | ASCO 2018 | Advanced stage Hodgkin lymphoma

Gilles Salles , Jun 5, 2018

CLL/SLL

Michael Hallek | ASCO 2018 | The potential of venetoclax for CLL patients with 17p deletion

Michael Hallek , Jun 5, 2018

FL

Sonali Smith | ASCO 2018 | Overview of the current advances in FL from ASCO

Sonali Smith , Jun 5, 2018

DLBCL,   FL

Bruce Cheson | ASCO 2018 | Potential for chemotherapy-free future in lymphoid malignancies

Sara Valente , Jun 5, 2018

DLBCL

Greg Nowakowski | ASCO 2018 | Gene expression profiling in ABC-type DLBCL patients: ROBUST phase III trial

Grzegorz Nowakowski , Jun 5, 2018